B Cell-Based Seamless Engineering of Antibody Fc Domains.
Engineering of monoclonal antibodies (mAbs) enables us to obtain mAbs with additional functions. In particular, modifications in antibody's Fc (fragment, crystallizable) region can provide multiple benefits such as added toxicity by drug conjugation, higher affinity to Fc receptors on immunocyt...
Main Authors: | Koji Hashimoto, Kohei Kurosawa, Akiho Murayama, Hidetaka Seo, Kunihiro Ohta |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5131995?pdf=render |
Similar Items
-
Engineering antibody Fc domains for improved therapeutic function
by: Kelton, William James
Published: (2015) -
Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
by: Hilma J. van der Horst, et al.
Published: (2020-10-01) -
Genetic Diversification by Somatic Gene Conversion
by: Kunihiro Ohta, et al.
Published: (2011-01-01) -
Engineering of aglycosylated antibody Fc for effector functions
by: Jung, Sang Taek
Published: (2014) -
Antibody Fc Engineering: Towards Better Therapeutics
Published: (2018)